“In effect, the era of high list prices and high rebates for insulin is over” In case you missed it, Alex Brill, founder and CEO of Matrix Global Advisors (MGA) and former policy director and chief economist for the House
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today is announcing the additions of Amanda Frost as Assistant Vice President, Research and Timothy Dube as Assistant Vice President, Regulatory Affairs. PCMA is also announcing new roles for Kristin Bass and
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing the additions of Angela Banks as Vice President, Policy; Jonathan Buxton as Director, State Affairs; and Peter Fjelstad as Director, State Regulatory and Legal Affairs, as well as new
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing the addition of Michael Power as Senior Director, State Affairs and new roles for Tim Dube, Melodie Shrader, Heather Cascone, and Randy Kane. Michael Power joins PCMA with a long list
Mark Merritt, chief executive of PCMA, dislikes the proposal and believes the Medicare coverage is a “sound program”
JC Scott speaks with Doug Long, Vice President of Industry Relations at IQVIA, about the impact of COVID-19 on the pharmaceutical market. IQVIA is a world leader in using data, technology, advanced analytics and expertise to help customers drive healthcare
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) is announcing the additions of Jack Linehan as General Counsel, Agnita Kote as Chief Financial Officer, Zach Pleasant as Director, Technology and Operations, and the promotion of Amanda Frost to Vice
(Washington, D.C.) — As drugstore lobbyists descend on Albany today, it is important to highlight how pharmacy benefit managers (PBMs) advocate for consumers and health plan sponsors in the fight to keep prescription drugs accessible and affordable. It is equally
Misguided Policies will Raise Costs for Patients, Employers, and Unions (Trenton, NJ) — The Pharmaceutical Care Management Association (PCMA) issued the following statement on the New Jersey Assembly’s hearing to examine the impact of PBMs on drug prices. “Pharmacy benefit
This week, the U.S. Senate Health, Education, Labor & Pensions (HELP) Committee considers legislation that would lower choice in the market by creating a one-size-fits all pharmacy benefit contracting model for health plans and employers. As Congress considers mandating contracting
©2024 PCMA. All Rights Reserved.
